Visit the Beamex web site
Click on the advert above to visit the company web site

Product category: Calibration and Testing Services, Consultancy and Learning
News Release from: Waters
Edited by the Manufacturingtalk Editorial Team on 23 June 2006

High performance liquid phase
separations

Request your FREE weekly copy of the Manufacturingtalk email newsletter. News about Calibration and Testing Services, Consultancy and Learning and more every issue. Click here for details.

Ultra Performance LC (UPLC) technology from Waters is taking centre stage at the 30th International Symposium on High Performance Liquid Phase Separations and Related Techniques.

As one of the industry's premier innovations to come along in the last 30 years, Ultra Performance LC (UPLC) technology from Waters takes center stage at the 30th International Symposium on High Performance Liquid Phase Separations and Related Techniques This year's conference is being held from June 17-23 at the San Francisco Marriott Hotel

Waters UPLC technology is a proven category of separation science.

The technology's sensitivity, resolution and speed eliminates significant time and cost-per-sample from the analytical process while simultaneously improving the quality of results.

The net result is that scientists realize significant productivity gains as they uncover information from complex samples.

Waters scientists are presenting more than 20 posters and papers centering on UPLC technology in poster topics as diverse as pharmaceutical analysis, proteomics, clinical, pharmaceutical separations and analysis, method development, life sciences and drug discovery, biotechnology, food safety, and metabolite ID.

Its enhanced levels of efficiency, sensitivity, and speed have caused research and industry scientists from other companies and academic institutions to make strategic investments in UPLC technology, often combining it with mass spectrometry for a system solution.

Waters UPLC, UPLC/MS systems and/or UPLC chemistries are featured in posters and presentations from no fewer than 62 scientists at: Amgen, Baxter Healthcare, Bristol-Myers Squibb, Dalian Institute of Chemical Physics (P.R.

China), Dow Chemical Co, Hospital Universitario Reina Sofia, (Spain), Imperial College (UK), Kings College (UK), Merck and Co , Pacific Northwest National Laboratory, Pfizer Global Research and Development, Tufts University, Unilver, University of New Mexico, U.S.

Drug Enforcement Administration and Wyeth.

UPLC-Enabled Bioseparations Focus in Booth 400 Waters is displaying two of its latest bioseparations innovations: UPLC Amino Acid and Peptide Analysis Application Solutions.

Designed to leverage the strengths that UPLC technology delivers in sensitivity, resolution and speed, both system solutions are equipped to meet the demands for high-quality analyses and come complete with chemistry, instrumentation, methodology, documentation and application support.

Featured in each solution is one of the company's newest UPLC-based detectors, the Acquity SQ Detector.

It is a benchtop, ultra-compact, single-quadrupole, atmospheric pressure ionization mass detector.

Together with an Acquity UPLC System and mass spectrometer, the Acquity SQD enables scientists to attain more information about the identity of pharmaceutical, biological, industrial and environmental compounds than conventional UV/Vis-based detector systems.

First introduced at this year's Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, both application solutions are currently shipping.

Waters' booth also includes a number of its premier chemistry brands: XBridge HPLC columns that provide LC method developers with greater degrees of improvement in high pH stability and higher level of performance; Acquity UPLC BEH columns that are based on highly efficient and rugged 1.7 um Bridged Ethyl Hybrid (BEH) particle technology; and Atlantis analytical columns that provide full LC/MS compatibility, superior peak shapes and excellent column-to-column reproducibility.

To complement these columns, the company is also exhibiting its Oasis family of sample preparation products.

Rounding out the exhibit are short courses by Waters senior scientists on FDA methods development and validation and developing SPE standards for sample preparation.

The company is also sponsoring two vendor seminars entitled "Introducing the New Standard for Polar Compound Retention in Reversed-Phase HPLC" on Wednesday, June 21st and "Theories, Concepts and Column Chemistries for UPLC" on Thursday, the 22nd in the Golden Gate Exhibit Hall at the hotel.

Waters: contact details and other news
Email this article to a colleague
Register for the free Manufacturingtalk email newsletter
Manufacturingtalk Home Page

Search the Pro-Talk network of sites

Visit the Beamex web site